Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Almac Diagnostics; Leica, Aperio; GenScript; University of Nebraska

NEW YORK (GenomeWeb News) – Almac Diagnostics said this week that it has launched a next-generation sequencing service to its portfolio, which also includes microarray, qPCR, and immunohistochemical offerings. Northern Ireland-based Almac said that the new NGS service will initially use the Illumina MiSeq platform.


Leica Biosystems has entered into a definitive agreement to acquire Aperio, expanding its digital pathology business. Terms of the acquisition were not disclosed.


GenScript this week said that it will participate in the Synthetic Yeast Genome Sc2.0 Project. The Piscataway, NJ-based firm said that it will complete the synthesis of a bulk length special yeast chromosome arm for the project, which is organized by a professor at Johns Hopkins University's School of Medicine.


The University of Nebraska Medical Center in Omaha has received around $142,000 from the University of Nebraska Foundation to purchase new medical research equipment, including a DNA sequencing instrument. The university didn't say which platform it intends to purchase.


In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.